OPTIMIZATION OF TKI SELECTION IN CML: BALANCING EFFICACY, SAFETY, AND PATIENT PREFERENCES
The long-term results from key studies such as ENESTnd, DASISION, and BFORE have helped guide first-line treatment decisions in chronic myeloid leukemia (CML). These studies compare the efficacy of different TKIs, including imatinib, dasatinib, and nilotinib, showing the potential benefits of second...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137924029560 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|